Experience With a Pediatric Summer Intensive Therapy Program

Neurodevelopmental Disorders Clinical Trial

Official title:

The Experience of Participating in a Pediatric Summer Intensive Therapy Program--A Mixed Methods Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04891328
• Other study ID #: 2058022
• Status: Completed
• Start date: May 24, 2021
• Est. completion date: October 1, 2021

Study information

• Verified date: March 2022
• Source: University of Missouri-Columbia
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to explore the lived experiences of children with neurodevelopmental diagnoses and their caregivers with an intensive model of therapy. Children will receive usual care during the summer intensive program and the investigators will access medical records to assess effectiveness. Children and caregivers will also be asked to participate in semi-structured interviews upon the completion of the episode of care.

Description:

The purpose of this study is to explore the lived experiences of children with neurodevelopmental diagnoses and their caregivers with an intensive model of therapy. Research questions include: 1.) What are the perceptions of children and caregivers about intensive therapy after participating in multiple intensive therapy episodes over time? 2.) Why do caregivers choose to continue with an intensive model of therapy periodically for their child with neurodevelopmental diagnoses? 3.) What were the outcomes for children with neurodevelopmental disabilities participating in an episode of intensive therapy? Children will receive usual care during the summer intensive program and the investigators will access medical records to assess effectiveness. Children and caregivers will also be asked to participate in semi-structured interviews upon the completion of the episode of care.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 13
• Est. completion date: October 1, 2021
• Est. primary completion date: September 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 4 Years to 15 Years

Eligibility

Inclusion Criteria:

• Children receiving therapy through the Children's Therapy Center's Tiger Intensive Program and their caregivers from May 24 to August 13 2021.

Exclusion Criteria:

• n/a

Related Conditions & MeSH terms

• Neurodevelopmental Disorders

Intervention

Other:
• Intensive therapy program
The intensive therapy program consists of physical therapy, occupational therapy, and speech therapy 3-6 hours x 4-5 days/week for 4 weeks. The individual therapies received will vary with the child/caregiver goals and be based on neuroplasticity and motor learning principles.

Locations

Country	Name	City	State
United States	University of Missouri Healthcare Children's Therapy Center	Columbia	Missouri

Sponsors (1)

Lead Sponsor	Collaborator
University of Missouri-Columbia

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Semi-structured interviews	Upon completion of the program, children and caregivers will participate in an interview about their experience	at discharge assessed up to 10 days
Primary	Canadian Occupational Performance Measure	Individualized client-centered performance measure	measured at discharge 4 weeks after enrollment
Secondary	Change in Lower extremity passive range of motion	Measured at ankle, knee, and hip with goniometer	Measured at day 1 and discharge 4 weeks later
Secondary	Change in Thomas Test	Hip flexor length test	Measured at day 1 and discharge 4 weeks later
Secondary	Change in popliteal angle	Hamstring length test	Measured at day 1 and discharge 4 weeks later
Secondary	Change in Gastrocnemius muscle length	Measured with goniometer	Measured at day 1 and discharge 4 weeks later
Secondary	Change in Kids Bestest	Balance measure for pediatric patients	Measured at day 1 and discharge 4 weeks later
Secondary	Change in m-CTSIB	Balance measure	Measured at day 1 and discharge 4 weeks later
Secondary	Change in Early Clinical Assessment of Balance	Balance measure	Measured at day 1 and discharge 4 weeks later
Secondary	Change in Segmental Assessment of Trunk Control (SATCO)	Measurement of trunk control	Measured at day 1 and discharge 4 weeks later
Secondary	Change in Edinburgh Visual Gait Scale	Observational Gait measure	Measured at day 1 and discharge 4 weeks later
Secondary	Change in Timed Up and Down Stairs	Measure of stair performance	Measured at day 1 and discharge 4 weeks later
Secondary	Change in Timed on and off the floor	Measure of transition from floor to standing	Measured at day 1 and discharge 4 weeks later
Secondary	Change in 6 minute walk test	Measure of walking performance	Measured at day 1 and discharge 4 weeks later
Secondary	Change in Peds QL	Pediatric quality of life measure	Measured at day 1 and discharge 4 weeks later
Secondary	Change in GOAL	patient reported measure of function mobility	Measured at day 1 and discharge 4 weeks later
Secondary	Change in Pediatric Evaluation of Disability Inventory	Measure of amount of disability	Measured at day 1 and discharge 4 weeks later
Secondary	Pediatric Balance Scale	Measure of balance	Measured at day 1 and discharge 4 weeks later